MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$91,800K
Net loss
-$91,716K
Deemed dividend
relating to inducement of...
$64K
Paid-in kind preferred
stock dividend
$20K
Loss before income
taxes
-$91,713K
Income tax expense
(benefit)
$3K
Product
$13,175K
License Royalty And
Other
$7,943K
Service
$5,432K
Loss from operations
-$61,308K
Total other expense
-$30,405K
Total revenues
$26,550K
Amortization of licensing
obligation premium
$1,911K
Interest income
$262K
Change in fair value of
derivative liability
$65K
Total operating
expenses
$87,858K
Compliance fees and other
expense, net
-$9,181K
Interest expense
$6,754K
Loss on debt
extinguishment
-$6,356K
Change in fair value of
warrant liabilities
$3,318K
Impairment of preferred
stock investment
$2,890K
Loss on issuance of
convertible notes with...
-$2,335K
Change in fair value of
debt
$1,809K
Selling, general and
administrative
$51,266K
Cost of revenues
$20,074K
Research and development
$15,025K
Amortization of acquired
intangible assets
$1,493K
Back
Back
Income Statement
source: myfinsight.com
Celularity Inc (CELU)
Celularity Inc (CELU)